Short Interest in BioLargo, Inc. (NASDAQ:BLGO) Declines By 65.1%

Key Points

• Short interest in BioLargo, Inc. decreased by 65.1% in August, falling from 200,200 shares to 69,900 shares as of August 31st, indicating a significant reduction in bearish sentiment.
• The company's stock performance shows a market cap of $71.08 million with a trading price of $0.23, and a price-to-earnings ratio of -23.00.
• BioLargo is focused on developing technologies to address critical environmental issues such as PFAS water contamination and air quality control.

BioLargo, Inc. (NASDAQ:BLGO - ) was the recipient of a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 69,900 shares, a decline of 65.1% from the August 15th total of 200,200 shares. Based on an average daily volume of 760,600 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 760,600 shares, the short-interest ratio is presently 0.1 days.

BioLargo Stock Performance

NASDAQ BLGO opened at $0.23 on Friday. The company has a quick ratio of 2.24, a current ratio of 2.31 and a debt-to-equity ratio of 0.03. BioLargo has a fifty-two week low of $0.16 and a fifty-two week high of $0.32. The business has a fifty day moving average of $0.19 and a 200-day moving average of $0.22. The stock has a market cap of $71.08 million, a price-to-earnings ratio of -23.00 and a beta of 0.11.

About BioLargo

BioLargo, Inc invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.